CN1868527A - Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases - Google Patents
Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases Download PDFInfo
- Publication number
- CN1868527A CN1868527A CN 200510010030 CN200510010030A CN1868527A CN 1868527 A CN1868527 A CN 1868527A CN 200510010030 CN200510010030 CN 200510010030 CN 200510010030 A CN200510010030 A CN 200510010030A CN 1868527 A CN1868527 A CN 1868527A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- cerebrovascular diseases
- treating cardiovascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating cardiovascular and cerebrovascular diseases is prepared from 10 Chinese-medicinal materials including ginseng, safflower, notoginseng, Chuan-xiong rhizome, etc.
Description
(1) technical field
What the present invention relates to is a kind of pharmaceutical product, specifically a kind of pharmaceutical product that is used for the treatment of cardiovascular and cerebrovascular disease.
(2) background technology
Cardiovascular and cerebrovascular disease comprises diseases such as hypertension, arteriosclerosis, cerebral thrombosis, cerebral infarction, subarachnoid hemorrhage, cerebral hemorrhage, coronary heart disease, angina pectoris, myocardial infarction.Its pathogenic factor is meant that coronary atherosclerosis is blocked lumen of vessels, causes myocardial ischemia, anoxia and the heart disease that causes, is called for short coronary heart disease; Angina pectoris is meant coronary insufficiency, and cardiac muscle suddenly gathers, temporary transient ischemia, the caused clinical syndrome of anoxia; Myocardial infarction is meant the myocardial ischemia necrosis; Cerebrovascular disease is meant and is used for the caused cerebrovascular disease of various cerebrovascular diseases, has a strong impact on the healthy of people.At present the Chinese medicine and western medicine of much controlling cardiovascular and cerebrovascular disease is arranged also, but therapeutic effect is undesirable, be difficult to cures, can only play mitigate the disease, and major part toxic side effect all.
(3) summary of the invention
The object of the present invention is to provide a kind of therapeutic effect good, curative effect is fast, and side effect is little, the Chinese medicine of the treatment cardiovascular and cerebrovascular disease that the treatment cost is low.
The present invention is achieved in that it is that Radix Ginseng 90-110 part, Flos Carthami 90-110 part, Radix Notoginseng 90-110 part, Rhizoma Chuanxiong 45-55 part, Radix Salviae Miltiorrhizae 45-55 part, Caulis Spatholobi 45-55 part, Radix Paeoniae Rubra 45-55 part, rhizoma sparganic 45-55 part, Sanguis Draxonis 13-18 part and succinum 13-18 part are formed by weight portion.
Above-mentioned raw materials is cleaned respectively, and pulverize separately is made powder after high temperature sterilize, oven dry, and mix homogeneously is made the powder product.
Radix Ginseng strongly invigorating primordial QI in the product of the present invention promotes the production of body fluid admittedly take off; The Flos Carthami promoting blood circulation to disperse blood clots and relieves pain; Radix Notoginseng hemostasis dissipating blood stasis, subduing swelling and relieving pain; The Rhizoma Chuanxiong promoting QI circulation for relieving depression, promoting blood circulation and stopping pain; The Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, nourishing blood to tranquillize the mind; The Caulis Spatholobi relaxing muscles and tendons to promote blood circulation; The Radix Paeoniae Rubra promoting blood circulation and stopping pain; The circulation of qi promoting of rhizoma sparganic removing blood stasis; The analgesic therapy of Sanguis Draxonis dissipating blood stasis; Succinum is relieving convulsion takes shelter.The present invention matches this 10 herbal medicine, plays blood and dissolving stasis altogether, tonifying QI to produce body fluid, the effect of tranquillizing the mind by relieving convulsion, pain relieving.Prove to have the effect of obvious coronary blood flow increasing through experimental result, thereby reduce myocardium consumption, have the allevating angina pectoris effect, the microcirculation improvement obstacle reduces blood viscosity, reduces vascular resistance, increases blood vessel elasticity.
Treat 69 routine hypertension, coronary heart disease, angina pectoris patient, the angina pectoris symptom remission rate is 59%, and the electrocardiogram effective percentage is 57.8%, and arrhythmia is 38.3%, and can see the blood pressure lowering effect for reducing blood fat.The present invention is made by pure Chinese medicine, has the curative effect height, instant effect, and cost is low, and side effect is little, advantages such as taking convenience, raw material is easy to get, and makes simply, realizes easily.
(4) specific embodiments
Be the ratio of Radix Ginseng 90-110 part, Flos Carthami 90-110 part, Radix Notoginseng 90-110 part, Rhizoma Chuanxiong 45-55 part, Radix Salviae Miltiorrhizae 45-55 part, Caulis Spatholobi 45-55 part, Radix Paeoniae Rubra 45-55 part, rhizoma sparganic 45-55 part, Sanguis Draxonis 13-18 part and succinum 13-18 part by weight, above-mentioned raw materials is cleaned respectively, pulverize separately is made powder after high temperature sterilize, oven dry, and mix homogeneously is made the powder product.
Be the ratio of 15 parts of 100 parts of Radix Ginsengs, 100 parts on Flos Carthami, 100 parts of Radix Notoginseng, 50 parts of Rhizoma Chuanxiongs, 50 parts of Radix Salviae Miltiorrhizaes, 50 parts of Caulis Spatholobis, 50 parts of Radix Paeoniae Rubra, 50 parts of rhizoma sparganic, 15 parts of Sanguis Draxonis and succinums by weight, above-mentioned raw materials is cleaned respectively, pulverize separately is made powder after high temperature sterilize, oven dry, and mix homogeneously is made the powder product.
Claims (2)
1, a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease is characterized in that: it is that Radix Ginseng 90-110 part, Flos Carthami 90-110 part, Radix Notoginseng 90-110 part, Rhizoma Chuanxiong 45-55 part, Radix Salviae Miltiorrhizae 45-55 part, Caulis Spatholobi 45-55 part, Radix Paeoniae Rubra 45-55 part, rhizoma sparganic 45-55 part, Sanguis Draxonis 13-18 part and succinum 13-18 part are formed by weight portion.
2, the Chinese medicine of treatment cardiovascular and cerebrovascular disease according to claim 1 is characterized in that: it is made up of for 15 parts 100 parts of weight portion Radix Ginsengs, 100 parts on Flos Carthami, 100 parts of Radix Notoginseng, 50 parts of Rhizoma Chuanxiongs, 50 parts of Radix Salviae Miltiorrhizaes, 50 parts of Caulis Spatholobis, 50 parts of Radix Paeoniae Rubra, 50 parts of rhizoma sparganic, 15 parts of Sanguis Draxonis and succinum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510010030 CN1868527A (en) | 2005-05-27 | 2005-05-27 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510010030 CN1868527A (en) | 2005-05-27 | 2005-05-27 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1868527A true CN1868527A (en) | 2006-11-29 |
Family
ID=37442393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510010030 Pending CN1868527A (en) | 2005-05-27 | 2005-05-27 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1868527A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104324134A (en) * | 2014-10-30 | 2015-02-04 | 梁小琼 | Traditional Chinese medicine composition for improving microcirculation and preparation method of traditional Chinese medicine composition |
| CN104940279A (en) * | 2015-07-27 | 2015-09-30 | 青岛蓝盛洋医药生物科技有限责任公司 | Application of Chinese herbal composition to preparation of medicine for treating myocardial infarction |
| CN107296838A (en) * | 2016-04-11 | 2017-10-27 | 曾建平 | Prevent and treat the compound method of the tcm product The Heroic Ones of heart infarction cerebral infarction |
| CN108210550A (en) * | 2017-08-01 | 2018-06-29 | 刘长林 | A kind of prescription for specially controlling cardiovascular and cerebrovascular disease |
-
2005
- 2005-05-27 CN CN 200510010030 patent/CN1868527A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104324134A (en) * | 2014-10-30 | 2015-02-04 | 梁小琼 | Traditional Chinese medicine composition for improving microcirculation and preparation method of traditional Chinese medicine composition |
| CN104940279A (en) * | 2015-07-27 | 2015-09-30 | 青岛蓝盛洋医药生物科技有限责任公司 | Application of Chinese herbal composition to preparation of medicine for treating myocardial infarction |
| CN107296838A (en) * | 2016-04-11 | 2017-10-27 | 曾建平 | Prevent and treat the compound method of the tcm product The Heroic Ones of heart infarction cerebral infarction |
| CN108210550A (en) * | 2017-08-01 | 2018-06-29 | 刘长林 | A kind of prescription for specially controlling cardiovascular and cerebrovascular disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106176931A (en) | A kind of for blood circulation promoting and blood stasis dispelling, anginal Chinese patent medicine and preparation technology thereof | |
| CN101168042A (en) | Traditional Chinese medicine preparation for curing cardiovascular and cerebrovascular diseases and preparing method | |
| CN104027500A (en) | Traditional Chinese medicinal formula for treating high blood fat, hypercholesterolemia and high blood viscosity | |
| CN103083400A (en) | Drug for treating cardiovascular disease | |
| CN1411830A (en) | Medicine for curing hypertension and its preparation method | |
| CN1868527A (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
| CN101306169B (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease | |
| CN100540035C (en) | The Chinese herbal medicine among the people of blood pressure lowering, blood fat, blood glucose | |
| CN102198228A (en) | Chinese medicinal preparation for treating hypertension | |
| CN105412279A (en) | Blood-fat-reducing traditional Chinese medicine health care product | |
| CN101979077B (en) | Traditional Chinese medicine for treating heart cerebrovascular diseases | |
| CN102908425B (en) | Medicine for treating heart diseases and thick blood lipid and preparation method of the medicine | |
| CN102274482A (en) | Chinese medicinal preparation for treating diabetes | |
| CN102228648B (en) | Chinese medicinal composition for treating icterohepatitis | |
| CN105311420A (en) | Traditional Chinese medicine composition for treating stroke and sequelae thereof | |
| CN106491776A (en) | A kind of Chinese lavipeditum composition for treating hygropyretic beriberi | |
| CN1110584A (en) | Traditional Chinese medicine for dephlogisticate | |
| CN104922647A (en) | Traditional Chinese medicine health product for preventing and adjuvantly treating coronary heart disease and preparation method thereof | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN100355434C (en) | Medicine for preventing and treating cardiovascular and cerebrovascular diseases | |
| CN1107336A (en) | "Xiongbining" medicine for treatment of paralyticus thorax | |
| CN103202995A (en) | Traditional Chinese medicine for treating myocardial infarction | |
| CN102846899A (en) | Storax tablet combination | |
| CN109692292A (en) | A kind of lavipeditum preparation compositions and preparation method thereof | |
| CN101244209B (en) | Medicament for preventing or treating cardiovascular and cerebrovascular diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned | ||
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |